Top Markets
#1 DeFiChain DeFiChain +1,198.24%
#2 Superfortune Superfortune +102.78%
#3 V.I.T.R.I.O.L. Network V.I.T.R.I.O.L. Network +82.96%
#4 The Black Bull The Black Bull +80.59%
#5 Metaplex Metaplex +79.35%
#6 TokenOS AI TokenOS AI +59.62%
#7 Nexus Nexus +56.52%
#8 Alien Worlds Alien Worlds +55.53%
#9 Magma Finance Magma Finance +47.14%
#10 Hamster Kombat Hamster Kombat +36.70%
Coin of the day
DeFiChain DeFiChain
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Virbac SA Virbac SA

Virbac SA

VIRP
Rangering i aksjer #3592
Virbac SA manufactures and sells a range of products and services for companion... Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Aksjekurs
$393.80
Markedsverdi
$3.30B
Endring (1 dag)
0.15%
Endring (1 år)
4.67%
Land
FR
Handel Virbac SA (VIRP)

Kategori

Healthcare
P/S-forhold for Virbac SA (VIRP)
P/S-forhold per July 2026 TTM: 1.90
Ifølge Virbac SA sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 1.90. Ved slutten av 2023 hadde selskapet et P/S-forhold på 2.39.
P/S-historikk for Virbac SA fra 2002 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 1.90 0.10%
2024 1.90 -20.75%
2023 2.39 51.21%
2022 1.58 -53.01%
2021 3.37 56.81%
2020 2.15 1.14%
2019 2.13 92.67%
2018 1.10 -8.14%
2017 1.20 -25.72%
2016 1.62 -25.62%
2015 2.17 14.35%
2014 1.90 6.88%
2013 1.78 -2.04%
2012 1.82 12.05%
2011 1.62 -17.65%
2010 1.97 45.76%
2009 1.35 19.90%
2008 1.13 -16.59%
2007 1.35 33.26%
2006 1.01 11.69%
2005 0.91 46.87%
2004 0.62 -14.23%
2003 0.72 7.76%
2002 0.67 0.00%
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
15.63 721.94%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.34 233.58%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.07 271.80%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.84 154.22%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
5.38 182.92%
CH